
The most recent iteration of the iaedp symposium just concluded in Baltimore. Speakers, many of whom are the same familiar faces appeared giving similar presentations as in years past. And many people will go back to their practices secure in the feeling of a job well done. And the normalization continues.
We know that eating disorders are among the deadliest psychiatric illnesses in medicine. That is the uncomfortable truth that very few are willing to discuss.
That is not debated in the literature. It is not speculative. It is not marginal data. And yet the urgency one would expect around a lethal psychiatric disorder is conspicuously absent from the professional culture that surrounds it.
There are no sustained national funding drives proportionate to mortality risk. Federal research allocations remain disproportionately low compared to other psychiatric and medical illnesses with lower fatality rates. The disparity between lethality and attention is measurable.
So is the normalization.
Inside treatment systems, the language feels technical and reassuring:
Levels of care.
Step-down programming.
Compliance metrics.
Utilization review cycles.
Coverage determinations.
The vocabulary signals coordination. It implies rigor. It suggests that decisions are anchored in standardized expertise. How wrong that is.
On the surface, the system does not appear malicious. It appears procedural. Structured. Measured. Confident. Each provider can justify decisions within guidelines. Each insurer can defend criteria. Each organization can cite consensus statements.
The illusion is not cruelty.
The illusion is normal.
Normal treatment duration.
Normal discharge criteria.
Normal reimbursement ceilings.
Normal consensus frameworks.
Individually, nothing appears aberrant. Collectively, the structure produces outcomes that mortality data have been warning about for decades.
Which raises an uncomfortable question:
If eating disorders carry one of the highest mortality rates in psychiatry, why is that reality not the organizing principle of our professional gatherings?
The Silence Around Mortality
At major symposiums, such as the recent iaedp symposium in Baltimore, the agenda is full. Panels are polished. Continuing education credits are awarded. Networking flourishes.
Eating disorder awareness week is upon us. It will be acknowledged by a crowd measuring in the tens. Some media outlets will pay lip service to it. Again, the same faces will talk about the same messaging. Events will be broadcast on social media attended by the same people, again, measuring in the tens. At the end of the week, the community will pat itself on the back and go back to bickering about social justice issues being allowed in treatment rooms.
But where is the sustained, central, data-driven reckoning with mortality?
Where are the plenary sessions that open with longitudinal survival curves?
Where are the transparent discussions of long-term relapse and death rates across levels of care?
Where are the public audits of whether treatment durations align with neurobiological recovery timelines rather than insurance reimbursement windows?
Mortality is referenced, occasionally acknowledged, sometimes framed as a reminder of seriousness. But it is rarely dissected structurally.
Why?
Because a full confrontation with mortality data does not just indict illness. It forces scrutiny of systems.
It forces questions about whether reimbursement structures shape clinical standards, whether “medical necessity” criteria are actuarial compromises rather than survival-based thresholds, whether discharge decisions are tethered to coverage limits rather than durable recovery, and whether professional consensus has been influenced by economic sustainability of treatment centers.
Where are the public questions and demands about how a credit card company is now going to oversee and operate an eating disorder residential treatment center? And how is that even legal? Let alone in the best interests of our families.
Those are not comfortable conference topics.
For that matter, why wasn’t that topic discussed at the REDC meeting which took place in Baltimore in a public forum with families who are suffering ? What matters more? Families and the mortality rate? Or protecting one of your fellow REDC members from public scrutiny? Profit margins or saving lives?
It is far easier to discuss innovation in therapeutic modalities than to ask whether overall mortality has shifted meaningfully in decades.
It is far easier to host panels on emerging frameworks than to ask why families still encounter rationed care for a disorder with documented lethal risk.
It is far easier to refine language than to examine outcomes.
If symposium speakers are drawn repeatedly from the same professional circles, presenting iterations of the same frameworks year after year, the ecosystem becomes self-reinforcing.
Professional consensus carries weight. But consensus is not formed in a vacuum. It is shaped by committees, insurers, funding realities, dominant voices, and organizational politics.
If dissenting clinicians, particularly those who challenge reimbursement norms or treatment duration standards are marginalized rather than platformed, scrutiny narrows.
If social positioning and internal professional politics consume oxygen that should be directed toward structural reform, then optics begin to substitute for outcomes.
Meanwhile, mortality remains stubborn.
And rarely centered.
The most powerful stabilizing force in the treatment ecosystem is not bad intention. It is normalization.
If revolving door admissions are normal, no one is failing.
If truncated treatment is normal, no one is responsible.
If mortality is described as “multifactorial or complex” urgency diffuses.
But when a system designed to treat a known lethal disorder operates for decades without materially altering lethal outcomes, and that fact does not dominate its most visible professional forums, something deeper is occurring.
The silence itself becomes data.
How is it possible that a field organized around a disorder with one of the highest psychiatric mortality rates can gather annually without centering that mortality as the primary measure of success or failure?
If mortality is not the headline metric, what is?
Attendance numbers?
Program growth?
Expanded diagnostic inclusivity?
Brand alignment?
Those may matter. But survival matters more.
Progress should be visible in survival curves.
Progress should be reflected in transparent long term remission and mortality data published without marketing filtration.
Progress should include open debate about reimbursement models, discharge standards, and treatment duration norms.
Instead, the field risks mistaking activity for advancement.
The same speakers.
The same frameworks.
The same consensus language.
And the mortality rate remains among the highest in mental health.
How Is That Progress?
If a system repeatedly fails to prevent lethal outcomes and still considers itself structurally sound, normalization has replaced urgency.
The institutions may be populated by compassionate individuals. Many clinicians care profoundly. But compassion operating within a misaligned architecture cannot compensate for structural design.
When families trust that care is calibrated toward survival, and insurers trust that criteria are defensible, and professional organizations trust that consensus equals correctness, scrutiny diminishes.
And when scrutiny diminishes, reform stalls.
The question is not whether people inside the system intend harm.
The question is whether the system is calibrated toward survival … or toward its own stability.
Until mortality is treated not as a sidebar statistic but as the central accountability metric, at symposiums, in reimbursement negotiations, in guideline committees, the illusion of normal will persist.
And children, adolescents, women, and men with eating disorders will continue to face a lethal illness inside a system that rarely speaks about death loudly enough.
That is not progress.
It is normalization of unacceptable outcomes.




